These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
(Mark
One)
|
|
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended September 30, 2010
|
|
OR
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from ______________ to ______________
|
Commission file number 1-12626
|
EASTMAN CHEMICAL COMPANY
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
62-1539359
|
|
(State or other jurisdiction of
|
(I.R.S. employer
|
|
incorporation or organization)
|
identification no.)
|
|
200 South Wilcox Drive
|
||
Kingsport, Tennessee
|
37662
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant's telephone number, including area code: (423) 229-2000
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES [X] NO [ ]
|
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
YES [X] NO [ ]
|
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer [X] Accelerated filer [ ]
Non-accelerated filer [ ] Smaller reporting company [ ]
(Do not check if a smaller reporting company)
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES [ ] NO [X]
|
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.
|
||
Class
|
Number of Shares Outstanding at September 30, 2010
|
|
Common Stock, par value $0.01 per share
|
72,127,905
|
|
ITEM
|
PAGE
|
1.
|
Financial Statements
|
|
3
|
||
4
|
||
5
|
||
6
|
||
2.
|
21
|
|
3.
|
41
|
|
4.
|
41
|
1.
|
42
|
|
1A.
|
43
|
|
2.
|
43
|
|
6.
|
43
|
44
|
Third Quarter
|
First Nine Months
|
|||||||
(Dollars in millions, except per share amounts)
|
2010
|
2009
|
2010
|
2009
|
||||
Sales
|
$
|
1,729
|
$
|
1,337
|
$
|
5,017
|
$
|
3,719
|
Cost of sales
|
1,284
|
1,009
|
3,847
|
2,952
|
||||
Gross profit
|
445
|
328
|
1,170
|
767
|
||||
Selling, general and administrative expenses
|
122
|
104
|
333
|
296
|
||||
Research and development expenses
|
43
|
33
|
115
|
101
|
||||
Asset impairments and restructuring charges, net
|
--
|
--
|
3
|
23
|
||||
Operating earnings
|
280
|
191
|
719
|
347
|
||||
Net interest expense
|
25
|
19
|
75
|
58
|
||||
Other charges (income), net
|
(3)
|
2
|
11
|
11
|
||||
Earnings before income taxes
|
258
|
170
|
633
|
278
|
||||
Provision for income taxes
|
88
|
69
|
214
|
110
|
||||
Net earnings
|
$
|
170
|
$
|
101
|
$
|
419
|
$
|
168
|
Earnings per share
|
||||||||
Basic
|
$
|
2.37
|
$
|
1.40
|
$
|
5.81
|
$
|
2.31
|
Diluted
|
$
|
2.33
|
$
|
1.38
|
$
|
5.70
|
$
|
2.29
|
Comprehensive Income
|
||||||||
Net earnings
|
$
|
170
|
$
|
101
|
$
|
419
|
$
|
168
|
Other comprehensive income (loss), net of tax
|
||||||||
Change in cumulative translation adjustment
|
28
|
2
|
7
|
17
|
||||
Change in unrecognized losses and prior service credits for benefit plans
|
2
|
--
|
11
|
(2)
|
||||
Change in unrealized gains (losses) on derivative instruments
|
(33)
|
(7)
|
(25)
|
(6)
|
||||
Total other comprehensive income (loss), net of tax
|
( 3)
|
(5)
|
(7)
|
9
|
||||
Comprehensive income
|
$
|
167
|
$
|
96
|
$
|
412
|
$
|
177
|
Retained Earnings
|
||||||||
Retained earnings at beginning of period
|
$
|
2,756
|
$
|
2,566
|
$
|
2,571
|
$
|
2,563
|
Net earnings
|
170
|
101
|
419
|
168
|
||||
Cash dividends declared
|
(32)
|
(32)
|
(96)
|
(96)
|
||||
Retained earnings at end of period
|
$
|
2,894
|
$
|
2,635
|
$
|
2,894
|
$
|
2,635
|
September 30,
|
December 31,
|
|||
(Dollars in millions, except per share amounts)
|
2010
|
2009
|
||
(Unaudited)
|
||||
Assets
|
||||
Current assets
|
||||
Cash and cash equivalents
|
$
|
642
|
$
|
793
|
Trade receivables, net
|
701
|
277
|
||
Miscellaneous receivables
|
66
|
102
|
||
Inventories
|
652
|
531
|
||
Other current assets
|
40
|
32
|
||
Total current assets
|
2,101
|
1,735
|
||
Properties
|
||||
Properties and equipment at cost
|
8,712
|
8,525
|
||
Less: Accumulated depreciation
|
5,546
|
5,415
|
||
Net properties
|
3,166
|
3,110
|
||
Goodwill
|
377
|
315
|
||
Other noncurrent assets
|
345
|
355
|
||
Total assets
|
$
|
5,989
|
$
|
5,515
|
Liabilities and Stockholders' Equity
|
||||
Current liabilities
|
||||
Payables and other current liabilities
|
$
|
936
|
$
|
800
|
Borrowings due within one year
|
4
|
--
|
||
Total current liabilities
|
940
|
800
|
||
Long-term borrowings
|
1,602
|
1,604
|
||
Deferred income tax liabilities
|
297
|
258
|
||
Post-employment obligations
|
1,198
|
1,221
|
||
Other long-term liabilities
|
142
|
119
|
||
Total liabilities
|
4,179
|
4,002
|
||
Stockholders' equity
|
||||
Common stock ($0.01 par value – 350,000,000 shares authorized; shares issued – 95,576,347 and 94,775,064 for 2010 and 2009, respectively)
|
1
|
1
|
||
Additional paid-in capital
|
710
|
661
|
||
Retained earnings
|
2,894
|
2,571
|
||
Accumulated other comprehensive loss
|
(392)
|
(385)
|
||
3,213
|
2,848
|
|||
Less: Treasury stock at cost (23,531,116 shares for 2010 and 22,389,696 shares for 2009 )
|
1,403
|
1,335
|
||
Total stockholders' equity
|
1,810
|
1,513
|
||
Total liabilities and stockholders' equity
|
$
|
5,989
|
$
|
5,515
|
First Nine Months
|
||||
(Dollars in millions)
|
2010
|
2009
|
||
Cash flows from operating activities
|
||||
Net earnings
|
$
|
419
|
$
|
168
|
|
||||
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
|
||||
Depreciation and amortization
|
212
|
203
|
||
Provision for deferred income taxes
|
52
|
165
|
||
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:
|
||||
(Increase) decrease in trade receivables
|
(397)
|
(35)
|
||
(Increase) decrease in inventories
|
(100)
|
141
|
||
Increase (decrease) in trade payables
|
56
|
(8)
|
||
Increase (decrease) in liabilities for employee benefits and incentive pay
|
9
|
(14)
|
||
Other items, net
|
46
|
48
|
||
Net cash provided by operating activities
|
297
|
668
|
||
Cash flows from investing activities
|
||||
Additions to properties and equipment
|
(133)
|
(268)
|
||
Proceeds from sale of assets and investments
|
11
|
25
|
||
Acquisitions and investments in joint ventures
|
(189)
|
(52)
|
||
Additions to capitalized software
|
(5)
|
(6)
|
||
Other items, net
|
(7)
|
(12)
|
||
Net cash used in investing activities
|
(323)
|
(313)
|
||
Cash flows from financing activities
|
||||
Net increase in commercial paper, credit facility, and other borrowings
|
1
|
23
|
||
Repayment of borrowings
|
(4)
|
(16)
|
||
Dividends paid to stockholders
|
(96)
|
(96)
|
||
Treasury stock purchases
|
(68)
|
--
|
||
Proceeds from stock option exercises and other items
|
41
|
15
|
||
Net cash used in financing activities
|
(126)
|
(74)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
1
|
--
|
||
Net change in cash and cash equivalents
|
(151)
|
281
|
||
Cash and cash equivalents at beginning of period
|
793
|
387
|
||
Cash and cash equivalents at end of period
|
$
|
642
|
$
|
668
|
ITEM
|
Page
|
7
|
|
Note 2.
Acquisitions
|
7
|
8
|
|
Note 4.
Inventories
|
9
|
Note 5.
Goodwill and Intangible Assets
|
9
|
9
|
|
Note 7.
Provision for Income Taxes
|
10
|
Note 8.
Borrowings
|
10
|
Note 9.
Retirement Plans
|
11
|
Note 10.
Environmental Matters
|
12
|
Note 11.
Commitments
|
12
|
Note 12.
Fair Value of Financial Instruments
|
13
|
Note 13.
Stockholders' Equity
|
16
|
Note 14.
Earnings and Dividends per Share
|
17
|
Note 15.
Share-Based Compensation Awards
|
17
|
Note 16.
Supplemental Cash Flow Information
|
17
|
Note 17.
Segment Information
|
18
|
Note 18.
Legal Matters
|
19
|
Note 19.
Subsequent Events
|
19
|
BASIS OF PRESENTATION
|
ACQUISITIONS
|
Dollars in millions
|
||
Current assets
|
$
|
48
|
Properties and equipment
|
33
|
|
Intangible assets
|
59
|
|
Other noncurrent assets
|
2
|
|
Goodwill
|
63
|
|
Current liabilities
|
(17)
|
|
Long-term liabilities
|
(28)
|
|
Total purchase price
|
$
|
160
|
3
.
|
ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES, NET
|
(Dollars in millions)
|
Balance at January 1, 2009
|
Provision/ Adjustments
|
Non-cash Reductions
|
Cash Reductions
|
Balance at December 31, 2009
|
|||||
Non-cash charges
|
$
|
--
|
$
|
179
|
$
|
(179)
|
$
|
--
|
$
|
--
|
Severance costs
|
5
|
23
|
--
|
(23)
|
5
|
|||||
Site closure and other restructuring costs
|
25
|
(2)
|
--
|
(18)
|
5
|
|||||
Total
|
$
|
30
|
$
|
200
|
$
|
(179)
|
$
|
(41)
|
$
|
10
|
Balance at January 1, 2010
|
Provision/ Adjustments
|
Non-cash Reductions
|
Cash Reductions
|
Balance at September 30, 2010
|
||||||
Non-cash charges
|
$
|
--
|
$
|
--
|
$
|
--
|
$
|
--
|
$
|
--
|
Severance costs
|
5
|
3
|
--
|
(6)
|
2
|
|||||
Site closure and other restructuring costs
|
5
|
--
|
--
|
--
|
5
|
|||||
Total
|
$
|
10
|
$
|
3
|
$
|
--
|
$
|
(6)
|
$
|
7
|
INVENTORIES
|
September 30,
|
December 31,
|
|||
(Dollars in millions)
|
2010
|
2009
|
||
At FIFO or average cost (approximates current cost)
|
||||
Finished goods
|
$
|
623
|
$
|
547
|
Work in process
|
193
|
168
|
||
Raw materials and supplies
|
299
|
262
|
||
Total inventories
|
1,115
|
977
|
||
LIFO reserve
|
(463)
|
(446)
|
||
Total inventories
|
$
|
652
|
$
|
531
|
GOODWILL AND INTANGIBLE ASSETS
|
(Dollars in millions)
|
CASPI Segment
|
PCI Segment
|
Other Segments
|
Total
|
||||
Reported balance at December 31, 2009
|
$
|
309
|
$
|
1
|
$
|
5
|
$
|
315
|
Additions
|
--
|
63
|
--
|
63
|
||||
Currency translation adjustments
|
(1)
|
--
|
--
|
(1)
|
||||
Reported balance at September 30, 2010
|
$
|
308
|
$
|
64
|
$
|
5
|
$
|
377
|
PAYABLES AND OTHER CURRENT LIABILITIES
|
September 30,
|
December 31,
|
|||
(Dollars in millions)
|
2010
|
2009
|
||
Trade creditors
|
$
|
511
|
$
|
433
|
Accrued payrolls, vacation, and variable-incentive compensation
|
146
|
125
|
||
Accrued taxes
|
35
|
33
|
||
Post-employment obligations
|
63
|
61
|
||
Interest payable
|
29
|
32
|
||
Other
|
152
|
116
|
||
Total payables and other current liabilities
|
$
|
936
|
$
|
800
|
PROVISION FOR INCOME TAXES
|
Third Quarter
|
First Nine Months
|
|||||||
(Dollars in millions)
|
2010
|
2009
|
2010
|
2009
|
||||
Provision for income taxes
|
$
|
88
|
$
|
69
|
$
|
214
|
$
|
110
|
Effective tax rate
|
34 %
|
40 %
|
34 %
|
39 %
|
8
.
|
BORROWINGS
|
September 30,
|
December 31,
|
|||
(Dollars in millions)
|
2010
|
2009
|
||
Borrowings consisted of:
|
||||
7% notes due 2012
|
$
|
152
|
$
|
152
|
6.30% notes due 2018
|
203
|
205
|
||
5.5% notes due 2019
|
250
|
250
|
||
7 1/4% debentures due 2024
|
497
|
497
|
||
7 5/8% debentures due 2024
|
200
|
200
|
||
7.60% debentures due 2027
|
298
|
298
|
||
Other
|
6
|
2
|
||
Total borrowings
|
1,606
|
1,604
|
||
Borrowings due within one year
|
(4)
|
--
|
||
Long-term borrowings
|
$
|
1,602
|
$
|
1,604
|
9
.
|
RETIREMENT PLANS
|
Summary of Components of Net Periodic Benefit Costs
|
||||||||
Third Quarter
|
First Nine Months
|
|||||||
(Dollars in millions)
|
2010
|
2009
|
2010
|
2009
|
||||
Service cost
|
$
|
11
|
$
|
10
|
$
|
33
|
$
|
31
|
Interest cost
|
21
|
22
|
63
|
65
|
||||
Expected return on assets
|
(24)
|
(25)
|
(77)
|
(74)
|
||||
Amortization of:
|
||||||||
Prior service credit
|
(4)
|
(4)
|
(12)
|
(12)
|
||||
Actuarial loss
|
10
|
8
|
32
|
25
|
||||
Net periodic benefit cost
|
$
|
14
|
$
|
11
|
$
|
39
|
$
|
35
|
Summary of Components of Net Periodic Benefit Costs
|
||||||||
Third Quarter
|
First Nine Months
|
|||||||
(Dollars in millions)
|
2010
|
2009
|
2010
|
2009
|
||||
Service cost
|
$
|
2
|
$
|
2
|
$
|
7
|
$
|
6
|
Interest cost
|
11
|
12
|
33
|
34
|
||||
Expected return on assets
|
(1)
|
(1)
|
(2)
|
(2)
|
||||
Amortization of:
|
||||||||
Prior service credit
|
(6)
|
(5)
|
(18)
|
(17)
|
||||
Actuarial loss
|
4
|
4
|
10
|
10
|
||||
Net periodic benefit cost
|
$
|
10
|
$
|
12
|
$
|
30
|
$
|
31
|
10
.
|
ENVIRONMENTAL MATTERS
|
11
.
|
COMMITMENTS
|
12.
|
FAIR
VALUE OF FINANCIAL INSTRUMENTS
|
September 30, 2010
|
December 31, 2009
|
|||||||
(Dollars in millions)
|
Recorded Amount
|
Fair Value
|
Recorded Amount
|
Fair Value
|
||||
Long-term borrowings
|
$
|
1,602
|
$
|
1,800
|
$
|
1,604
|
$
|
1,656
|
(Dollars in millions)
|
Fair Value Measurements at September 30, 2010
|
|||||||
Description
|
September 30,
2010
|
Quoted Prices in Active Markets for Identical Assets (Level 1)
|
Significant Other Observable Inputs (Level 2)
|
Significant Unobservable Inputs (Level 3)
|
||||
Derivative Assets
|
$
|
93
|
$
|
--
|
$
|
93
|
$
|
--
|
Derivative Liabilities
|
(93)
|
--
|
(93)
|
--
|
||||
$
|
--
|
$
|
--
|
$
|
--
|
$
|
--
|
(Dollars in millions)
|
Fair Value Measurements at December 31, 2009
|
|||||||
Description
|
December 31, 2009
|
Quoted Prices in Active Markets for Identical Assets (Level 1)
|
Significant Other Observable Inputs (Level 2)
|
Significant Unobservable Inputs (Level 3)
|
||||
Derivative Assets
|
$
|
52
|
$
|
--
|
$
|
52
|
$
|
--
|
Derivative Liabilities
|
(21)
|
--
|
(21)
|
--
|
||||
$
|
31
|
$
|
--
|
$
|
31
|
$
|
--
|
(Dollars in millions)
|
Fair Value
|
|||||
Derivative Assets
|
Statement of Financial Position Location
|
September 30, 2010
|
December 31, 2009
|
|||
Commodity contracts
|
Other current assets
|
$
|
--
|
$
|
7
|
|
Foreign exchange contracts
|
Other current assets
|
14
|
14
|
|||
Foreign exchange contracts
|
Other noncurrent assets
|
11
|
11
|
|||
$
|
25
|
$
|
32
|
(Dollars in millions)
|
Fair Value
|
|||||
Derivative Liabilities
|
Statement of Financial Position Location
|
September 30, 2010
|
December 31, 2009
|
|||
Commodity contracts
|
Payables and other current liabilities
|
$
|
4
|
$
|
1
|
|
Foreign exchange contracts
|
Payables and other current liabilities
|
3
|
--
|
|||
Foreign exchange contracts
|
Other noncurrent liabilities
|
3
|
--
|
|||
Forward starting interest rate swap contracts
|
Other noncurrent liabilities
|
18
|
--
|
|||
$
|
28
|
$
|
1
|
Third Quarter
|
||||||||||
(Dollars in millions)
|
||||||||||
Derivatives' Cash Flow Hedging Relationships
|
Amount after tax of gain/ (loss) recognized in Other Comprehensive Income on derivatives (effective portion)
|
Location of gain/(loss) reclassified from Accumulated Other Comprehensive Income into income (effective portion)
|
Pre-tax amount of gain/(loss) reclassified from Accumulated Other Comprehensive Income into income (effective portion)
|
|||||||
September 30, 2010
|
September 30, 2009
|
September 30, 2010
|
September 30, 2009
|
|||||||
Commodity contracts
|
$
|
6
|
$
|
1
|
Cost of sales
|
$
|
(2)
|
$
|
--
|
|
Foreign exchange contracts
|
(30)
|
(8)
|
Sales
|
11
|
5
|
|||||
Forward starting interest rate swap contracts
|
(9)
|
--
|
-- |
--
|
||||||
$
|
(33)
|
$
|
(7)
|
$
|
9
|
$
|
5
|
First Nine Months
|
||||||||||
(Dollars in millions)
|
||||||||||
Derivatives' Cash Flow Hedging Relationships
|
Amount after tax of gain/ (loss) recognized in Other Comprehensive Income on derivatives (effective portion)
|
Location of gain/(loss) reclassified from Accumulated Other Comprehensive Income into income (effective portion)
|
Pre-tax amount of gain/(loss) reclassified from Accumulated Other Comprehensive Income into income (effective portion)
|
|||||||
September 30, 2010
|
September 30, 2009
|
September 30, 2010
|
September 30, 2009
|
|||||||
Commodity contracts
|
$
|
(6)
|
$
|
6
|
Cost of sales
|
$
|
2
|
$
|
(9)
|
|
Foreign exchange contracts
|
(7)
|
(12)
|
Sales
|
34
|
19
|
|||||
Forward starting interest rate swap contracts
|
(12)
|
--
|
-- |
--
|
||||||
$
|
(25)
|
$
|
(6)
|
$
|
36
|
$
|
10
|
13.
|
STOCKHOLDERS'
EQUITY
|
(Dollars in millions)
|
Common Stock at Par Value
$
|
Paid-in Capital
$
|
Retained Earnings
$
|
Accumulated Other Comprehensive Income (Loss)
$
|
Treasury Stock at Cost
$
|
Total Stockholders' Equity
$
|
Balance at December 31, 2009
|
1
|
661
|
2,571
|
(385)
|
(1,335)
|
1,513
|
Net Earnings
|
--
|
--
|
419
|
--
|
--
|
419
|
Cash Dividends Declared
(1)
|
--
|
--
|
(96)
|
--
|
--
|
(96)
|
Other Comprehensive Income (Loss)
|
--
|
--
|
--
|
(7)
|
--
|
(7)
|
Share-Based Compensation Expense
(2)
|
--
|
15
|
--
|
--
|
--
|
15
|
Stock Option Exercises
|
--
|
35
|
--
|
--
|
--
|
35
|
Other
(3)
|
--
|
(1)
|
--
|
--
|
--
|
(1)
|
Stock Repurchases
|
--
|
--
|
--
|
--
|
(68)
|
(68)
|
Balance at September 30, 2010
|
1
|
710
|
2,894
|
(392)
|
(1,403)
|
1,810
|
(1)
|
Includes cash dividends declared, but unpaid.
|
(2)
|
Includes the fair value of equity share-based awards recognized for share-based compensation.
|
(3)
|
Includes tax benefits relating to the difference between the amounts deductible for federal income taxes over the amounts charged to income for book value purposes credited to paid-in capital and other items.
|
(Dollars in millions)
|
Cumulative Translation Adjustment
$
|
Unrecognized Losses and Prior Service Credits for Benefit Plans
$
|
Unrealized Gains (Losses) on Derivative Instruments
$
|
Unrealized Losses on Investments
$
|
Accumulated Other Comprehensive Income (Loss)
$
|
Balance at December 31, 2008
|
60
|
(414)
|
20
|
(1)
|
(335)
|
Period change
|
17
|
(74)
|
7
|
--
|
(50)
|
Balance at December 31, 2009
|
77
|
(488)
|
27
|
(1)
|
(385)
|
Period change
|
7
|
11
|
(25)
|
--
|
(7)
|
Balance at September 30, 2010
|
84
|
(477)
|
2
|
(1)
|
(392)
|
14
.
|
EARNINGS AND DIVIDENDS PER SHARE
|
Third Quarter
|
First Nine Months
|
||||||
2010
|
2009
|
2010
|
2009
|
||||
Shares used for earnings per share calculation (in millions):
|
|||||||
Basic
|
71.9
|
72.6
|
72.1
|
72.5
|
|||
Diluted
|
73.3
|
73.5
|
73.6
|
73.3
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
(Dollars in millions)
|
First Nine Months
|
|||
2010
|
2009
|
|||
Current assets
|
$
|
--
|
$
|
7
|
Other assets
|
6
|
35
|
||
Current liabilities
|
34
|
5
|
||
Long-term liabilities and equity
|
6
|
1
|
||
Total
|
$
|
46
|
$
|
48
|
SEGMENT INFORMATION
|
Third Quarter
|
||||
(Dollars in millions)
|
2010
|
2009
|
||
Sales
|
||||
CASPI
|
$
|
406
|
$
|
338
|
Fibers
|
301
|
257
|
||
PCI
|
534
|
377
|
||
Performance Polymers
|
222
|
165
|
||
Specialty Plastics
|
266
|
200
|
||
Total Sales
|
$
|
1,729
|
$
|
1,337
|
First Nine Months
|
||||
(Dollars in millions)
|
2010
|
2009
|
||
Sales
|
||||
CASPI
|
$
|
1,195
|
$
|
890
|
Fibers
|
842
|
779
|
||
PCI
|
1,557
|
997
|
||
Performance Polymers
|
638
|
509
|
||
Specialty Plastics
|
785
|
544
|
||
Total Sales
|
$
|
5,017
|
$
|
3,719
|
Third Quarter
|
||||
(Dollars in millions)
|
2010
|
2009
|
||
Operating Earnings (Loss)
|
||||
CASPI
|
$
|
91
|
$
|
84
|
Fibers
|
90
|
79
|
||
PCI
|
77
|
31
|
||
Performance Polymers
|
6
|
(8)
|
||
Specialty Plastics
|
31
|
13
|
||
Total Operating Earnings by Segment
|
295
|
199
|
||
Other
|
(15)
|
(8)
|
||
Total Operating Earnings
|
$
|
280
|
$
|
191
|
First Nine Months
|
||||
(Dollars in millions)
|
2010
|
2009
|
||
Operating Earnings (Loss)
|
||||
CASPI
(1)
|
$
|
251
|
$
|
148
|
Fibers
(1)
|
252
|
222
|
||
PCI
(1) (2)
|
183
|
22
|
||
Performance Polymers
(1)
|
(1)
|
(19)
|
||
Specialty Plastics
(1)
|
73
|
3
|
||
Total Operating Earnings by Segment
|
758
|
376
|
||
Other
|
(39)
|
(29)
|
||
Total Operating Earnings
|
$
|
719
|
$
|
347
|
(1) | First nine months 2009 includes a restructuring charge primarily for a severance program of $5 million, $4 million, $6 million, $4 million, and $4 million in the CASPI, Fibers, PCI, Performance Polymers and Specialty Plastics segments, respectively. |
(2) | First nine months 2010 includes restructuring charges of $3 million, primarily for severance in the PCI segment. See Note 3, "Asset Impairments and Restructuring Charges, Net", for additional information. |
September 30,
|
December 31,
|
|||
(Dollars in millions)
|
2010
|
2009
|
||
Assets by Segment
(1)
|
||||
CASPI
|
$
|
1,278
|
$
|
1,128
|
Fibers
|
863
|
726
|
||
PCI
|
1,201
|
845
|
||
Performance Polymers
|
591
|
575
|
||
Specialty Plastics
|
990
|
910
|
||
Total Assets by Segment
|
4,923
|
4,184
|
||
Corporate Assets
|
1,066
|
1,331
|
||
Total Assets
|
$
|
5,989
|
$
|
5,515
|
(1) |
The chief operating decision maker holds segment management accountable for accounts receivable, inventory, fixed assets, goodwill, and intangibles.
|
LEGAL MATTERS
|
SUBSEQUENT EVENTS
|
ITEM
|
Page
|
22
|
|
22
|
|
23
|
|
24
|
|
27
|
|
32
|
|
33
|
|
37
|
|
38
|
|
·
|
Company and segment operating earnings, net earnings, and diluted earnings per share ("EPS") excluding asset impairments and restructuring charges, net; and
|
·
|
Cash flows from operating activities excluding the impact of adoption of amended accounting guidance for transfers of financial assets.
|
·
|
In the Fibers segment, the Korean acetate tow facility was acquired and commenced production in first quarter. Commercial operations have commenced and customer qualifications are continuing.
|
·
|
In the PCI segment, Genovique, a global producer of specialty non-phthalate plasticizers for water-based adhesives and other applications, was acquired in second quarter.
|
·
|
In the Specialty Plastics segment, the monomer manufacturing facility and the first Eastman Tritan
TM
copolyester polymer manufacturing facility in Kingsport, Tennessee commenced production in first quarter. The Company is adding another 30 thousand metric tons of resin capacity for Tritan
TM
, which is expected to be online by the end of 2011.
|
·
|
In the Specialty Plastics segment, the Company is expanding its capacity for cyclohexane dimethanol ("CHDM") modified polymers, a monomer used in the manufacture of copolyester, by approximately 25 percent and expects the capacity to be online in two phases in late 2011 and in 2012.
|
·
|
In the Specialty Plastics segment, the Company is expanding its cellulose triacetate
capacity by approximately 70 percent, with the new capacity expected to be online in first quarter 2012.
|
·
|
In the CASPI segment, the Company has commenced the third expansion of the Company’s hydrogenated hydrocarbon resins capacity in Middelburg, the Netherlands which will increase this capacity by an additional 20 percent and is expected to be online in second half 2011. The Company is also expanding its Longview, Texas hydrogenated hydrocarbon resins capacity which is expected to be online in early 2011.
|
Third Quarter
|
Volume Effect
|
Price Effect
|
Product
Mix Effect
|
Exchange
Rate
Effect
|
||||||||||
(Dollars in millions)
|
2010
|
2009
|
Change
|
|||||||||||
Sales
|
$
|
1,729
|
$
|
1,337
|
29 %
|
18 %
|
9 %
|
3 %
|
(1) %
|
|||||
First Nine Months
|
Volume Effect
|
Price Effect
|
Product
Mix Effect
|
Exchange
Rate
Effect
|
||||||||||
(Dollars in millions)
|
2010
|
2009
|
Change
|
|||||||||||
Sales
|
$
|
5,017
|
$
|
3,719
|
35 %
|
20 %
|
11 %
|
4 %
|
-- %
|
|||||
Third Quarter
|
First Nine Months
|
|||||||||||
(Dollars in millions)
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
||||||
Gross Profit
|
$
|
445
|
$
|
328
|
36 %
|
$
|
1,170
|
$
|
767
|
53 %
|
||
As a percentage of sales
|
26 %
|
25 %
|
23 %
|
21 %
|
||||||||
Third Quarter
|
First Nine Months
|
|||||||||||
(Dollars in millions)
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
||||||
Selling, General and Administrative Expenses
|
$
|
122
|
$
|
104
|
17 %
|
$
|
333
|
$
|
296
|
13 %
|
||
Research and Development Expenses
|
43
|
33
|
30 %
|
115
|
101
|
14 %
|
||||||
$
|
165
|
$
|
137
|
20 %
|
$
|
448
|
$
|
397
|
13 %
|
|||
As a percentage of sales
|
10 %
|
10 %
|
9 %
|
11 %
|
Third Quarter
|
First Nine Months
|
|||||||||||
(Dollars in millions)
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
||||||
Operating earnings
|
$
|
280
|
$
|
191
|
47 %
|
$
|
719
|
$
|
347
|
>100 %
|
||
Asset impairments and restructuring charges, net
|
--
|
--
|
3
|
23
|
||||||||
Operating earnings excluding asset impairments and restructuring charges, net
|
$
|
280
|
$
|
191
|
47 %
|
$
|
722
|
$
|
370
|
95 %
|
Third Quarter
|
First Nine Months
|
|||||||||||
(Dollars in millions)
|
2010
|
2009
|
Change
|
2010
|
2009
|
Change
|
||||||
Gross interest costs
|
$
|
27
|
$
|
23
|
$
|
81
|
$
|
73
|
||||
Less: Capitalized interest
|
1
|
3
|
2
|
10
|
||||||||
Interest expense
|
26
|
20
|
30 %
|
79
|
63
|
25 %
|
||||||
Interest income
|
1
|
1
|
4
|
5
|
||||||||
Net interest expense
|
$
|
25
|
$
|
19
|
32 %
|
$
|
75
|
$
|
58
|
29 %
|
||
Third Quarter
|
First Nine Months
|
|||||||
(Dollars in millions)
|
2010
|
2009
|
2010
|
2009
|
||||
Foreign exchange transaction (gains) losses, net
|
$
|
(2)
|
$
|
--
|
$
|
7
|
$
|
2
|
Investment (gains) losses, net
|
(3)
|
(1)
|
(2)
|
4
|
||||
Other, net
|
2
|
3
|
6
|
5
|
||||
Other charges (income), net
|
$
|
(3)
|
$
|
2
|
$
|
11
|
$
|
11
|
Third Quarter
|
First Nine Months
|
|||||||
(Dollars in millions)
|
2010
|
2009
|
2010
|
2009
|
||||
Provision for income taxes
|
$
|
88
|
$
|
69
|
$
|
214
|
$
|
110
|
Effective tax rate
|
34 %
|
40 %
|
34 %
|
39 %
|
Net Earnings and Diluted Earnings per Share
|
||||||||
Third Quarter
|
||||||||
2010
|
2009
|
|||||||
(Dollars in millions, except diluted EPS)
|
$
|
EPS
|
$
|
EPS
|
||||
Net earnings
|
$
|
170
|
$
|
2.33
|
$
|
101
|
$
|
1.38
|
First Nine Months
|
||||||||
2010
|
2009
|
|||||||
(Dollars in millions, except diluted EPS)
|
$
|
EPS
|
$
|
EPS
|
||||
Net earnings
|
$
|
419
|
$
|
5.70
|
$
|
168
|
$
|
2.29
|
Asset impairments and restructuring charges, net of tax
|
2
|
0.03
|
14
|
0.20
|
||||
Net earnings excluding asset impairments and restructuring charges, net of tax
|
$
|
421
|
$
|
5.73
|
$
|
182
|
$
|
2.49
|
CASPI Segment
|
|||||||||||||||||
Third Quarter
|
First Nine Months
|
||||||||||||||||
Change
|
Change
|
||||||||||||||||
(Dollars in millions)
|
2010
|
2009
|
$
|
%
|
2010
|
2009
|
$
|
%
|
|||||||||
Sales
|
$
|
406
|
$
|
338
|
$
|
68
|
20 %
|
$
|
1,195
|
$
|
890
|
$
|
305
|
34 %
|
|||
Volume effect
|
28
|
8 %
|
163
|
18 %
|
|||||||||||||
Price effect
|
37
|
11 %
|
87
|
10 %
|
|||||||||||||
Product mix effect
|
9
|
3 %
|
56
|
6 %
|
|||||||||||||
Exchange rate effect
|
(6)
|
(2) %
|
(1)
|
-- %
|
|||||||||||||
Operating earnings
|
91
|
84
|
7
|
8 %
|
251
|
148
|
103
|
70 %
|
|||||||||
Asset impairments and restructuring charges, net
|
--
|
--
|
--
|
--
|
5
|
(5)
|
|||||||||||
Operating earnings excluding asset impairments and restructuring charges, net
|
91
|
84
|
7
|
8 %
|
251
|
153
|
98
|
64 %
|
Fibers Segment
|
|||||||||||||||||
Third Quarter
|
First Nine Months
|
||||||||||||||||
Change
|
Change
|
||||||||||||||||
(Dollars in millions)
|
2010
|
2009
|
$
|
%
|
2010
|
2009
|
$
|
%
|
|||||||||
Sales
|
$
|
301
|
$
|
257
|
$
|
44
|
17 %
|
$
|
842
|
$
|
779
|
$
|
63
|
8 %
|
|||
Volume effect
|
30
|
12 %
|
44
|
6 %
|
|||||||||||||
Price effect
|
--
|
-- %
|
2
|
-- %
|
|||||||||||||
Product mix effect
|
15
|
5 %
|
17
|
2 %
|
|||||||||||||
Exchange rate effect
|
(1)
|
-- %
|
--
|
-- %
|
|||||||||||||
Operating earnings
|
90
|
79
|
11
|
14 %
|
252
|
222
|
30
|
14 %
|
|||||||||
Asset impairments and restructuring charges, net
|
--
|
--
|
--
|
--
|
4
|
(4)
|
|||||||||||
Operating earnings excluding asset impairments and restructuring charges, net
|
90
|
79
|
11
|
14 %
|
252
|
226
|
26
|
12 %
|
PCI Segment
|
||||||||||||||||
Third Quarter
|
First Nine Months
|
|||||||||||||||
Change
|
Change
|
|||||||||||||||
(Dollars in millions)
|
2010
|
2009
|
$
|
%
|
2010
|
2009
|
$
|
%
|
||||||||
Sales
|
$
|
534
|
$
|
377
|
$
|
157
|
42 %
|
$
|
1,557
|
$
|
997
|
$
|
560
|
56 %
|
||
Volume effect
|
83
|
22 %
|
277
|
28 %
|
||||||||||||
Price effect
|
67
|
18 %
|
234
|
23 %
|
||||||||||||
Product mix effect
|
9
|
3 %
|
49
|
5 %
|
||||||||||||
Exchange rate effect
|
(2)
|
(1) %
|
--
|
-- %
|
||||||||||||
Operating earnings
|
77
|
31
|
46
|
>100 %
|
183
|
22
|
161
|
>100 %
|
||||||||
Asset impairments and restructuring charges, net
|
--
|
--
|
--
|
3
|
6
|
(3)
|
||||||||||
Operating earnings excluding asset impairments and restructuring charges, net
|
77
|
31
|
46
|
>100 %
|
186
|
28
|
158
|
>100 %
|
||||||||
Performance Polymers Segment
|
||||||||||||||||
Third Quarter
|
First Nine Months
|
|||||||||||||||
Change
|
Change
|
|||||||||||||||
(Dollars in millions)
|
2010
|
2009
|
$
|
%
|
2010
|
2009
|
$
|
%
|
||||||||
Sales
|
$
|
222
|
$
|
165
|
$
|
57
|
34 %
|
$
|
638
|
$
|
509
|
$
|
129
|
25 %
|
||
Volume effect
|
44
|
27 %
|
67
|
13 %
|
||||||||||||
Price effect
|
14
|
8 %
|
69
|
13 %
|
||||||||||||
Product mix effect
|
(1)
|
(1) %
|
(7)
|
(1) %
|
||||||||||||
Exchange rate effect
|
--
|
-- %
|
--
|
-- %
|
||||||||||||
Operating earnings (loss)
|
6
|
(8)
|
14
|
>100 %
|
(1)
|
(19)
|
18
|
95 %
|
||||||||
Asset impairments and restructuring charges, net
|
--
|
--
|
--
|
--
|
4
|
(4)
|
||||||||||
Operating earnings (loss) excluding asset impairments and restructuring charges, net
|
6
|
(8)
|
14
|
>100 %
|
(1)
|
(15)
|
14
|
93 %
|
||||||||
Specialty Plastics Segment
|
|||||||||||||||||
Third Quarter
|
First Nine Months
|
||||||||||||||||
Change
|
Change
|
||||||||||||||||
(Dollars in millions)
|
2010
|
2009
|
$
|
%
|
2010
|
2009
|
$
|
%
|
|||||||||
Sales
|
$
|
266
|
$
|
200
|
$
|
66
|
33 %
|
$
|
785
|
$
|
544
|
$
|
241
|
44 %
|
|||
Volume effect
|
55
|
27 %
|
201
|
37 %
|
|||||||||||||
Price effect
|
3
|
1 %
|
1
|
-- %
|
|||||||||||||
Product mix effect
|
9
|
5 %
|
35
|
6 %
|
|||||||||||||
Exchange rate effect
|
(1)
|
-- %
|
4
|
1 %
|
|||||||||||||
Operating earnings
|
31
|
13
|
18
|
>100 %
|
73
|
3
|
70
|
>100 %
|
|||||||||
Asset impairments and restructuring charges, net
|
--
|
--
|
--
|
--
|
4
|
(4)
|
|||||||||||
Operating earnings excluding asset impairments and restructuring charges, net
|
31
|
13
|
18
|
>100 %
|
73
|
7
|
66
|
>100 %
|
Third Quarter
|
||||||||||||||
(Dollars in millions)
|
2010
|
2009
|
Change
|
Volume Effect
|
Price Effect
|
Product
Mix Effect
|
Exchange
Rate
Effect
|
|||||||
United States and Canada
|
$
|
946
|
$
|
737
|
28 %
|
18 %
|
10 %
|
-- %
|
-- %
|
|||||
Asia Pacific
|
369
|
282
|
31 %
|
15 %
|
9 %
|
6 %
|
1 %
|
|||||||
Europe, Middle East, and Africa
|
291
|
222
|
31 %
|
20 %
|
7 %
|
10 %
|
(6) %
|
|||||||
Latin America
|
123
|
96
|
28 %
|
19 %
|
10 %
|
(1) %
|
-- %
|
|||||||
$
|
1,729
|
$
|
1,337
|
29 %
|
18 %
|
9 %
|
3 %
|
(1) %
|
First Nine Months
|
||||||||||||||
(Dollars in millions)
|
2010
|
2009
|
Change
|
Volume Effect
|
Price Effect
|
Product
Mix Effect
|
Exchange
Rate
Effect
|
|||||||
United States and Canada
|
$
|
2,746
|
$
|
2,096
|
31 %
|
19 %
|
12 %
|
-- %
|
-- %
|
|||||
Asia Pacific
|
1,058
|
769
|
38 %
|
18 %
|
10 %
|
9 %
|
1 %
|
|||||||
Europe, Middle East, and Africa
|
852
|
607
|
40 %
|
23 %
|
3 %
|
15 %
|
(1) %
|
|||||||
Latin America
|
361
|
247
|
46 %
|
31 %
|
15 %
|
-- %
|
-- %
|
|||||||
$
|
5,017
|
$
|
3,719
|
35 %
|
20 %
|
11 %
|
4 %
|
-- %
|
First Nine Months
|
||||
(Dollars in millions)
|
2010
|
2009
|
||
Net cash provided by (used in)
|
||||
Operating activities
|
$
|
297
|
$
|
668
|
Investing activities
|
(323)
|
(313)
|
||
Financing activities
|
(126)
|
(74)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
1
|
--
|
||
Net change in cash and cash equivalents
|
(151)
|
281
|
||
|
||||
Cash and cash equivalents at beginning of period
|
793
|
387
|
||
Cash and cash equivalents at end of period
|
$
|
642
|
$
|
668
|
First Nine Months
|
||||
(Dollars in millions)
|
2010
|
2009
|
||
Net cash provided by operating activities
|
$
|
297
|
$
|
668
|
Impact of adoption of amended accounting guidance
(1)
|
200
|
--
|
||
Net cash provided by operating activities excluding item
|
497
|
668
|
||
Additions to properties and equipment
|
(133)
|
(268)
|
||
Dividends paid to stockholders
|
(96)
|
(96)
|
||
Free Cash Flow
|
$
|
268
|
$
|
304
|
(1)
|
First nine months 2010 cash from operating activities reflected the adoption of amended accounting guidance for transfers of financial assets which resulted in $200 million of receivables, which were previously accounted for as sold and removed from the balance sheet when transferred under the accounts receivable securitization program, being included on the first quarter balance sheet as trade receivables, net. This increase in receivables reduced cash from operations by $200 million in first quarter 2010.
|
(Dollars in millions)
|
Payments Due for
|
|||||||||||||
Period
|
Notes and Debentures
|
Credit Facility Borrowings and Other
|
Interest Payable
|
Purchase Obligations
|
Operating Leases
|
Other Liabilities (a)
|
Total
|
|||||||
2010
|
$
|
--
|
$
|
4
|
$
|
25
|
$
|
65
|
$
|
8
|
$
|
134
|
$
|
236
|
2011
|
2
|
--
|
110
|
252
|
23
|
61
|
448
|
|||||||
2012
|
152
|
--
|
105
|
246
|
18
|
56
|
577
|
|||||||
2013
|
--
|
--
|
99
|
232
|
12
|
58
|
401
|
|||||||
2014
|
--
|
--
|
99
|
37
|
8
|
60
|
204
|
|||||||
2015 and beyond
|
1,448
|
--
|
889
|
155
|
19
|
981
|
3,492
|
|||||||
Total
|
$
|
1,602
|
$
|
4
|
$
|
1,327
|
$
|
987
|
$
|
88
|
$
|
1,350
|
$
|
5,358
|
·
|
increases in volume due to the recovery from the global recession and continued substitution of Eastman products for other materials and new applications for existing products;
|
·
|
the volatility of market prices for raw materials and energy to continue and that the Company will continue to use pricing and hedging strategies to offset this volatility and for raw material and energy costs to be higher than 2009;
|
·
|
the cellulose acetate tow manufacturing facility and related business in Korea, which was acquired and operational in first quarter 2010, to be fully integrated into the Fibers segment's production and sales processes in 2011;
|
·
|
to continue to progress with the introduction of its new Eastman Tritan
TM
copolyester product line, which it supplies from the monomer manufacturing facility and its first Tritan
TM
copolyester polymer manufacturing facility in Kingsport, Tennessee;
|
·
|
to complete the sale of the PET business and related assets and technology of its Performance Polymers segment to DAK Americas, LLC during fourth quarter of 2010 for cash of $600 million before transaction fees and working capital adjustments at closing;
|
·
|
the acquisition of Genovique Specialties Corporation, a global producer of specialty non-phthalate plasticizers for water-based adhesives and other applications, completed in the second quarter, to be accretive to the Company's full-year earnings per share;
|
·
|
depreciation and amortization to be slightly higher than 2009 primarily due to expected completion of manufacturing facilities in 2010;
|
·
|
net interest expense to increase compared with 2009 primarily due to lower capitalized interest and higher average borrowings;
|
·
|
the effective tax rate to be approximately 34 percent;
|
·
|
capital spending to be approximately $225 million for required maintenance, discretionary infrastructure projects, and certain strategic growth initiatives;
|
·
|
pension expense to be slightly higher than 2009, and U.S. defined benefit pension plan funding to be $135 million;
|
·
|
to generate greater than $300 million of positive free cash flow (operating cash flow excluding the $200 million impact of adoption of amended accounting guidance, less capital expenditures and dividends);
|
·
|
priorities
for uses of available cash to be payment of the quarterly cash dividend, funding targeted growth initiatives (including organic initiatives, joint ventures and acquisitions) and defined benefit pension plans, and repurchasing shares; and
|
·
|
full year 2010 earnings per share to be greater than $7.00 excluding charges related to restructuring actions.
|
Period
|
Total Number of Shares Purchased
(1)
|
Average Price Paid Per Share
(2)
|
Total Number of Shares Purchased as Part of Publicly Announced Plans
or Programs
(3)
|
Approximate Dollar
Value (in millions) that May Yet Be Purchased Under the Plans or Programs
(3)
|
||||
July 1 - 31, 2010
|
273,162
|
$
|
54.93
|
272,900
|
$
|
27
|
||
August 1 - 31, 2010
|
0
|
$
|
--
|
0
|
$
|
327
|
||
September 1 - 30, 2010
|
0
|
$
|
--
|
0
|
$
|
327
|
||
Total
|
273,162
|
$
|
54.93
|
272,900
|
(1)
|
Shares repurchased under a Company announced repurchase plan and shares surrendered to the Company by employees to satisfy individual tax withholding obligations upon vesting of previously issued shares of restricted common stock.
|
(2)
|
Average price paid per share reflects the weighted average purchase price paid for share repurchases and the closing price of Eastman stock on the business day the shares were surrendered by the employee stockholder to satisfy individual tax withholding.
|
(3)
|
In August 2010, the Company's Board of Directors authorized an additional repurchase of up to $300 million of the Company's outstanding common stock at such times, in such amounts, and on such terms, as determined to be in the best interests of the Company. The authorization is in addition to the remaining amount available under the previous October 2007 $700 million repurchase authorization of the Company's outstanding common stock. As of September 30, 2010, a total of 10.9 million shares have been repurchased for a total amount of approximately $673 million. For additional information, see
Note 13, "Stockholders' Equity",
to the Company's unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.
|
Eastman Chemical Company
|
|||
Date: November 1, 2010
|
By:
|
/s/Curtis E. Espeland | |
Curtis E. Espeland
|
|||
Senior Vice President and Chief Financial Officer
|
EXHIBIT
INDEX
|
Sequential
|
|||
Exhibit
|
Page
|
|||
Number
|
Description
|
Number
|
||
3.01
|
Amended and Restated Certificate of Incorporation of Eastman Chemical Company, as amended (incorporated herein by reference to Exhibit 3.01 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2010)
|
|||
47-58
|
||||
4.01
|
Form of Eastman Chemical Company common stock certificate as amended February 1, 2001 (incorporated herein by reference to Exhibit 4.01 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2001)
|
|||
4.02
|
Indenture, dated as of January 10, 1994, between Eastman Chemical Company and The Bank of New York, as Trustee (the "Indenture") (incorporated herein by reference to Exhibit 4(a) to the Company's Current Report on Form 8-K dated January 10, 1994)
|
|||
4.03
|
Form of 7 1/4% Debentures due January 15, 2024 (incorporated herein by reference to Exhibit 4(d) to the Company's Current Report on Form 8-K dated January 10, 1994)
|
|||
4.04
|
Officers' Certificate pursuant to Sections 201 and 301 of the Indenture (incorporated herein by reference to Exhibit 4(a) to the Company's Current Report on Form 8-K dated June 8, 1994)
|
|||
4.05
|
Form of 7 5/8% Debentures due June 15, 2024 (incorporated herein by reference to Exhibit 4(b) to the Company's Current Report on Form 8-K dated June 8, 1994)
|
|||
4.06
|
Form of 7.60% Debentures due February 1, 2027 (incorporated herein by reference to Exhibit 4.08 to the Company's Annual Report on Form 10-K for the year ended December 31, 1996)
|
|||
4.07
|
Form of 7% Notes due April 15, 2012 (incorporated herein by reference to Exhibit 4.09 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2002)
|
|||
4.08
|
Officer's Certificate pursuant to Sections 201 and 301 of the Indenture related to 7.60% Debentures due February 1, 2027 (incorporated herein by reference to Exhibit 4.09 to the Company's Annual Report on Form 10-K for the year ended December 31, 2006)
|
|||
4.09
|
Form of 5.500% Notes due 2019 (incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K dated November 2, 2009)
|
|||
4.10
|
July 7, 2010 Letter Amendment to $200,000,000 Accounts Receivable Securitization agreement dated July 9, 2008 (amended February 18, 2009, and July 8, 2009), between the Company and The Bank of Tokyo-Mitsubishi UFJ, Ltd., as agent. (incorporated herein by reference to Exhibit 4.09 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2009 [and Exhibit 4.10 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2010)]
|
|||
4.11
|
Amended and Restated Credit Agreement, dated as of April 3, 2006 (the "Credit Agreement") among Eastman Chemical Company, the Lenders named therein, and Citigroup Global Markets , Inc. and J. P. Morgan Securities Inc., as joint lead arrangers, as amended on November 16, 2007 and March 10, 2008 (incorporated herein by reference to Exhibit 4.11 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2006 and Exhibit 4.10 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2008)
|
EXHIBIT INDEX
|
Sequential
|
|||
Exhibit
|
Page
|
|||
Number
|
Description
|
Number
|
||
4.12
|
Form of 6.30% Notes due 2018 (incorporated herein by reference to Exhibit 4.14 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2003)
|
|||
59-60
|
||||
61-62
|
||||
63-74
|
||||
75-86
|
||||
87
|
||||
88
|
||||
89
|
||||
90
|
||||
91
|
||||
101.INS
|
XBRL Instance Document (furnished, not filed)
|
|||
101.SCH
|
XBRL Taxonomy Extension Schema (furnished, not filed)
|
|||
101.CAL
|
XBRL Taxonomy Calculation Linkbase (furnished, not filed)
|
|||
101.LAB
|
XBRL Taxonomy Label Linkbase (furnished, not filed)
|
|||
101.PRE
|
XBRL Presentation Linkbase Document (furnished, not filed)
|
|||
101.DEF
|
XBRL Definition Linkbase Document (furnished, not filed)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|